Richard W Mott - Net Worth and Insider Trading
Richard W Mott Net Worth
The estimated net worth of Richard W Mott is at least $6 Million dollars as of 2024-06-10. Richard W Mott is the Director of Treace Medical Concepts Inc and owns about 1,072,944 shares of Treace Medical Concepts Inc (TMCI) stock worth over $6 Million. Details can be seen in Richard W Mott's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Richard W Mott has not made any transactions after 2024-05-24 and currently still holds the listed stock(s).
Transaction Summary of Richard W Mott
Richard W Mott Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Richard W Mott owns 3 companies in total, including Endologix Inc (ELGXQ) , Lyra Therapeutics Inc (LYRA) , and Treace Medical Concepts Inc (TMCI) .
Click here to see the complete history of Richard W Mott’s form 4 insider trades.
Insider Ownership Summary of Richard W Mott
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
ELGXQ | Endologix Inc | 2020-06-19 | director |
LYRA | Lyra Therapeutics Inc | 2020-04-30 | 10 percent owner |
TMCI | Treace Medical Concepts Inc | 2024-05-24 | director |
Richard W Mott Latest Holdings Summary
Richard W Mott currently owns a total of 1 stock. Richard W Mott owns 1,072,944 shares of Treace Medical Concepts Inc (TMCI) as of May 24, 2024, with a value of $6 Million.
Latest Holdings of Richard W Mott
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
TMCI | Treace Medical Concepts Inc | 2024-05-24 | 1,072,944 | 5.82 | 6,244,534 |
Holding Weightings of Richard W Mott
Richard W Mott Form 4 Trading Tracker
According to the SEC Form 4 filings, Richard W Mott has made a total of 16 transactions in Treace Medical Concepts Inc (TMCI) over the past 5 years, including 3 buys and 13 sells. The most-recent trade in Treace Medical Concepts Inc is the acquisition of 18,000 shares on May 24, 2024, which cost Richard W Mott around $93,420.
Insider Trading History of Richard W Mott
- 1
Richard W Mott Trading Performance
GuruFocus tracks the stock performance after each of Richard W Mott's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Richard W Mott is %. GuruFocus also compares Richard W Mott's trading performance to market benchmark return within the same time period. The performance of stocks bought by Richard W Mott within 3 months outperforms times out of transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Richard W Mott's insider trading performs compared to the benchmark.
Performance of Richard W Mott
Richard W Mott Ownership Network
Ownership Network List of Richard W Mott
Ownership Network Relation of Richard W Mott
Richard W Mott Owned Company Details
What does Endologix Inc do?
Who are the key executives at Endologix Inc?
Richard W Mott is the director of Endologix Inc. Other key executives at Endologix Inc include director & CEO and Director John Onopchenko , Chief Medical Officer Matthew Thompson , and Controller and Corp Secretary Timothy Nicholas Brady .
Endologix Inc (ELGXQ) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Endologix Inc (ELGXQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Endologix Inc (ELGXQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Endologix Inc (ELGXQ)'s detailed insider trading history can be found in Insider Trading Tracker table.
Endologix Inc Insider Transactions
Richard W Mott Mailing Address
Above is the net worth, insider trading, and ownership report for Richard W Mott. You might contact Richard W Mott via mailing address: 1221 Crossman Avenue, Sunnyvale Ca 94089.